These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Neuropathology of Gerstmann-Sträussler-Scheinker disease. Bugiani O; Giaccone G; Piccardo P; Morbin M; Tagliavini F; Ghetti B Microsc Res Tech; 2000 Jul; 50(1):10-5. PubMed ID: 10871543 [TBL] [Abstract][Full Text] [Related]
11. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Ishizawa K; Komori T; Shimazu T; Yamamoto T; Kitamoto T; Shimazu K; Hirose T Acta Neuropathol; 2002 Oct; 104(4):342-50. PubMed ID: 12200619 [TBL] [Abstract][Full Text] [Related]
12. An autopsy report of three kindred in a Gerstmann-Sträussler-Scheinker disease P105L family with a special reference to prion protein, tau, and beta-amyloid. Ishizawa K; Mitsufuji T; Shioda K; Kobayashi A; Komori T; Nakazato Y; Kitamoto T; Araki N; Yamamoto T; Sasaki A Brain Behav; 2018 Oct; 8(10):e01117. PubMed ID: 30240140 [TBL] [Abstract][Full Text] [Related]
13. Gerstmann-Sträussler-Scheinker disease (PRNP P102L): amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165. Piccardo P; Ghetti B; Dickson DW; Vinters HV; Giaccone G; Bugiani O; Tagliavini F; Young K; Dlouhy SR; Seiler C J Neuropathol Exp Neurol; 1995 Nov; 54(6):790-801. PubMed ID: 7595652 [TBL] [Abstract][Full Text] [Related]
14. Structure of Tau filaments in Prion protein amyloidoses. Hallinan GI; Hoq MR; Ghosh M; Vago FS; Fernandez A; Garringer HJ; Vidal R; Jiang W; Ghetti B Acta Neuropathol; 2021 Aug; 142(2):227-241. PubMed ID: 34128081 [TBL] [Abstract][Full Text] [Related]
16. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Dlouhy SR; Hsiao K; Farlow MR; Foroud T; Conneally PM; Johnson P; Prusiner SB; Hodes ME; Ghetti B Nat Genet; 1992 Apr; 1(1):64-7. PubMed ID: 1363809 [TBL] [Abstract][Full Text] [Related]
17. An extensive network of PHF tau-rich dystrophic neurites permeates neocortex and nearly all neuritic and diffuse amyloid plaques in Alzheimer disease. Schmidt ML; DiDario AG; Lee VM; Trojanowski JQ FEBS Lett; 1994 May; 344(1):69-73. PubMed ID: 8181568 [TBL] [Abstract][Full Text] [Related]
18. Unusual clinical and molecular-pathological profile of gerstmann-Sträussler-Scheinker disease associated with a novel PRNP mutation (V176G). Simpson M; Johanssen V; Boyd A; Klug G; Masters CL; Li QX; Pamphlett R; McLean C; Lewis V; Collins SJ JAMA Neurol; 2013 Sep; 70(9):1180-5. PubMed ID: 23857164 [TBL] [Abstract][Full Text] [Related]
19. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Bramblett GT; Trojanowski JQ; Lee VM Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956 [TBL] [Abstract][Full Text] [Related]
20. A novel PRNP Y218N mutation in Gerstmann-Sträussler-Scheinker disease with neurofibrillary degeneration. Alzualde A; Indakoetxea B; Ferrer I; Moreno F; Barandiaran M; Gorostidi A; Estanga A; Ruiz I; Calero M; van Leeuwen FW; Atares B; Juste R; Rodriguez-Martínez AB; López de Munain A J Neuropathol Exp Neurol; 2010 Aug; 69(8):789-800. PubMed ID: 20613639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]